Table 2.
Postoperative outcomes (n=30)
| Perioperative period | |
| Postoperative complications, n (%) | |
| Liver failure | 2 (6.7) |
| Infection | 0 |
| Bleeding | 0 |
| Pathology | |
| Grade 2 | 19 (63.3) |
| Grade 3 | 10 (33.3) |
| Grade 4 | 1 (3.3) |
| R0 surgical margin | 30 (100) |
| Postoperative hospital stay (days) | 9.4±4.0 (6–22) |
| POD of drain removal | 8.6±2.5 (6–15) |
| Mortality within 30 days | 0 |
| Lab test | |
| Maximum AST (UI/l) | 204.8±35.8 |
| Maximum ALT (UI/l) | 164.3±46.2 |
| Maximum bilirubin (mmol/l) | 26.3±6.4 |
| Minimum prothrombin acitivity (%) | 71.3±10.3 |
| Follow-up | |
| Recurrence | 13 (43.3%) |
| Contralateral liver | 6 (20.0%) |
| Extrahepatic metastasis | 7 (23.3%) |
| Mortality | 6 (20%) |
AST, alanine aminotransferase; ALT, alanine aminotransferase.